Azelaic Acid: The One Ingredient That Does Everything

What Is Azelaic Acid?

Azelaic acid (AZA) is a naturally occurring C9 dicarboxylic acid found in whole grains — wheat, rye, and barley — and produced industrially via controlled fermentation of Pityrosporum yeasts or by ozonolysis of oleic acid. It has been used in medical dermatology since the 1980s, when early clinical trials demonstrated its efficacy for acne and hyperpigmentation in darker skin tones.

What sets azelaic acid apart from most skincare actives is the breadth of its validated applications: it is a single molecule with four distinct, simultaneous mechanisms of action covering acne, rosacea, hyperpigmentation, and post-inflammatory marks — conditions that usually require separate ingredients, each with its own tolerability challenges. It is also remarkably gentle and is one of the few prescription-grade actives cleared for use during pregnancy.

---

How Azelaic Acid Works: Four Mechanisms in One

1. Tyrosinase Inhibition — Fades Pigment at the Source

Azelaic acid competitively inhibits tyrosinase — the rate-limiting enzyme in melanin synthesis — by competing with L-tyrosine for the enzyme's active site. It additionally reduces expression of tyrosinase-related proteins TRP-1 and TRP-2, and increases intracellular reduced thioredoxin, itself a potent tyrosinase inhibitor.

Critically, AZA shows selective cytotoxicity toward hyperactive melanocytes: it disrupts mitochondrial function in abnormally active pigment cells without damaging normally active melanocytes. This selectivity explains why it fades post-inflammatory hyperpigmentation and melasma effectively without risking hypopigmentation of normal skin — a key safety advantage over hydroquinone.

2. Anti-Keratinization — Clears Acne and Congestion

Azelaic acid normalizes follicular keratinization — the process by which the cells lining hair follicles are shed. When this process is disrupted, the shed cells accumulate and plug follicles, forming microcomedones: the precursor to every acne lesion. AZA exerts antiproliferative and cytostatic effects on keratinocytes, reducing excessive proliferation and restoring orderly differentiation. The result is fewer blocked pores and reduced new acne formation.

3. Antimicrobial Activity — Targets P. acnes Without Resistance Risk

Azelaic acid is bacteriostatic against both aerobic and anaerobic bacteria, including Cutibacterium acnes (formerly P. acnes) — the key organism implicated in inflammatory acne. Its antimicrobial mechanism operates via inhibition of mitochondrial oxidoreductases and bacterial protein synthesis. Importantly, unlike antibiotic acne treatments, azelaic acid does not induce bacterial resistance — a significant practical and public health advantage for long-term acne management.

4. Anti-Inflammatory and ROS Scavenging — Calms Redness and Rosacea

Azelaic acid inhibits the production of reactive oxygen species (ROS) by activated neutrophils and directly scavenges free radicals. In the specific context of rosacea, AZA suppresses KLK5 (kallikrein-related peptidase 5) and the downstream antimicrobial peptide cathelicidin (LL-37), directly modulating the TLR2/KLK5/LL-37 innate immune axis that drives papulopustular rosacea pathology. This targeted mechanism is why it is FDA-approved specifically for this condition.

---

What Azelaic Acid Treats: The Evidence

Acne Vulgaris

Azelaic acid 20% cream has been studied extensively in head-to-head trials against topical antibiotics, benzoyl peroxide, and tretinoin:

• A landmark trial published in Acta Dermato-Venereologica found 20% azelaic acid cream was equally effective to 0.05% tretinoin cream for reducing comedones, with meaningfully fewer local side effects.
• It reduced inflammatory and non-inflammatory lesions comparably to topical antibiotics (erythromycin, clindamycin) while avoiding resistance induction.
• A 2023 systematic review of azelaic acid in acne concluded it is an effective and well-tolerated option for mild-to-moderate acne vulgaris, particularly for patients with darker skin tones where post-inflammatory hyperpigmentation is a co-concern.

Rosacea

This is azelaic acid's highest-evidence indication. The FDA approved:

• 15% gel (Finacea) for mild-to-moderate papulopustular rosacea
• 15% foam for the same indication

A phase 3 randomized, double-blind, vehicle-controlled trial of 961 subjects demonstrated that the investigator global assessment success rate with azelaic acid 15% foam was significantly greater than vehicle (32.0% vs. 23.5%; P<0.001). Head-to-head comparative trials show azelaic acid outperforms metronidazole on several efficacy measures — including inflammatory lesion count and erythema severity — making it a preferred first-line option in many dermatology guidelines.

For more detail on the rosacea-specific evidence, see /azelaic-acid-rosacea.

Melasma and Hyperpigmentation

A 2023 systematic review and meta-analysis in Cureus (PMC10339666) analyzed six randomized controlled trials including 673 melasma patients and found:

• Azelaic acid produced significant improvements in MASI scores versus vehicle
• Efficacy was broadly comparable to hydroquinone 4% with a more favorable safety profile
• Azelaic acid 20% cream produced significantly greater decreases in pigmentary intensity than vehicle in darker-skinned patients at 24 weeks

A 2024 PubMed-indexed study specifically evaluated 15% azelaic acid gel for post-inflammatory erythema and post-inflammatory hyperpigmentation (PIH) in acne vulgaris — finding significant improvements in both — reflecting its dual benefit in the acne-pigmentation complex common in patients with Fitzpatrick skin types III–VI.

Post-Inflammatory Hyperpigmentation (PIH)

PIH is the persistent dark mark left by any inflammatory lesion — acne, eczema, insect bites. Azelaic acid's combined anti-inflammatory and anti-pigment mechanisms address PIH at both the cause (inflammation) and the result (excess melanin). This makes it particularly valuable for skin of color, where PIH is often a greater concern than the original lesion.

---

Azelaic Acid Concentrations: OTC vs. Prescription

Higher concentrations produce more robust results but also more transient stinging on application. Most OTC products at 10% are effective for mild concerns and appropriate for those new to the ingredient or with sensitive skin. Prescription formulations require a consultation with a dermatologist or prescribing clinician, who can also assess whether azelaic acid is the most appropriate choice for your specific presentation.

---

How to Use Azelaic Acid

Basic Protocol

1. Cleanse. Use a gentle, non-stripping cleanser suited to your skin type.
2. Apply azelaic acid. Apply a thin, even layer to the face (or affected areas). A pea-to-dime-sized amount is usually sufficient for the full face.
3. Frequency. Begin with once daily (evening is convenient) for 1–2 weeks. Build to twice daily (morning and evening) as tolerated, which is the recommended regimen for the FDA-approved rosacea indications.
4. Follow with moisturizer as needed — particularly if you experience dryness or mild flaking in the first weeks.
5. Apply SPF 30+ every morning without exception. Azelaic acid enhances photosensitivity to a lesser extent than retinoids, but all pigment-targeting actives work against themselves if sun exposure is uncontrolled.

Can You Use It Morning and Evening?

Yes. Unlike retinoids, azelaic acid is photostable and can be used in both the morning and evening routine. Using it in the morning (under SPF) is effective and not inadvisable. For rosacea indications, twice-daily application is the standard clinical protocol.

How Long Before Results?

• Acne inflammation: improvements visible within 4–8 weeks of consistent use
• Pigmentation and tone: measurable improvement at 8–12 weeks; full results at 24 weeks for melasma
• Rosacea erythema and papules: significant improvement documented at 12–15 weeks in clinical trials

Consistency is the key variable. Missing weeks extends the timeline for visible improvement.

---

Side Effects and Tolerability

Azelaic acid is one of the better-tolerated prescription-grade actives available. The most commonly reported effects are:

• Transient stinging or burning on application — particularly pronounced in the first 2–4 weeks and most noticeable with prescription-strength 15% and 20% formulations. This typically resolves as the skin adapts.
• Mild dryness or flaking — less common than with retinoids; usually managed with a good moisturizer.
• Contact dermatitis (rare true allergy) — distinguished from irritation by extending beyond the application zone or presenting with hives/blistering.

Because stinging is transient and not a sign of harm, it is not a reason to discontinue — but if burning persists beyond week 4 or is severe, reduce frequency or switch to a lower concentration, and consult a clinician.

---

Who Should Use Azelaic Acid?

Ideal candidates:

• Adults with mild-to-moderate acne, particularly with concurrent PIH
• People with rosacea (especially papulopustular subtype) — seek prescription strength
• Anyone with melasma, uneven skin tone, or hyperpigmentation who cannot use or has not responded to retinoids, kojic acid, or alpha-arbutin
• Pregnant individuals needing an effective topical active — AZA is one of very few options in this group
• Patients with darker skin tones (Fitzpatrick III–VI) who are at higher risk from hydroquinone-related ochronosis

Who should be cautious:

• Those with very sensitive skin or active rosacea erythema (start with 10% OTC and build)
• Anyone already on prescription azelaic acid who is considering adding OTC — redundant and may increase irritation

---

Pregnancy and Breastfeeding

Azelaic acid is one of the very few topical actives with an established safety record in pregnancy. Topical absorption is less than 4% of the applied dose, blood levels after topical application are within the normal physiological range for endogenous AZA, and animal studies have shown no teratogenic or embryotoxic potential even at high doses. The FDA previously categorized it as Pregnancy Category B.

Azelaic acid is generally considered safe during breastfeeding at normal topical doses given the low systemic absorption. As with any medication in pregnancy or lactation, use under the guidance of a healthcare provider.

This makes it one of the only effective actives for treating acne and hyperpigmentation in pregnancy — conditions that commonly worsen due to hormonal shifts — alongside topical erythromycin and glycolic acid.

---

Combining Azelaic Acid with Other Actives

For a direct comparison of azelaic acid and niacinamide — including which to choose and how to combine them — see Azelaic Acid vs. Niacinamide.

---

Azelaic Acid vs. Other Hyperpigmentation Actives

Azelaic acid's combination of strong evidence, pregnancy safety, and selectivity for hyperactive melanocytes (no risk of normal-skin hypopigmentation) makes it the strongest option when pregnancy is a factor and a top-tier choice more broadly.

---

Frequently Asked Questions

See below.